Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
1143studies shown
Showing 289-300 of 1,143
Drug study icon
CompletedNCT03097133

Intranasal Esketamine for depression

This study is completed in the United States, in France, in Canada, .... It is testing intranasal Esketamine for depression.

In Canada
Depression, SuicidalityDrugFrom 18 Years to 64 Years
Countries
United States, France, Canada, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression, Suicidality
Drug study icon
CompletedNCT01714713

EVP-6124 (Alpha-7 nAChR) for schizophrenia

This study is completed in the United States, in Australia, in Canada, .... It is testing EVP-6124 (Alpha-7 nAChR) for schizophrenia.

In Canada
SchizophreniaDrugFrom 18 Years to 50 Years
Countries
United States, Australia, Canada, ...
Sponsor
FORUM Pharmaceuticals Inc
Condition
Schizophrenia
Drug study icon
CompletedNCT05113771

Liafensine for Depression

This study is completed in the United States and in Canada. It is testing liafensine for Depression.

In Canada
DepressionDrugFrom 18 Years to 70 Years
Countries
United States, Canada
Sponsor
Denovo Biopharma LLC
Condition
Depression
Drug study icon
TerminatedNCT05169710

Investigational Drug for depression

This study was terminated in the United States, in Canada, in Bulgaria, .... It is testing investigational Drug for depression.

In Canada
Depression, BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, Canada, Bulgaria, ...
Sponsor
Sumitomo Pharma America, Inc.
Condition
Depression, Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.